中国医学科学院血液病医院（血液学研究所）博士毕业生 住院医师

发表文章：1.Chenxing Du*, Gang An#, 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib, Leuk Lymphoma. 2019 Dec 16:1-10.

2. TT Yu*, CX Du*, XK Ma*, M Hao#. Polycomb-like Protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a, Mol Cancer Res. 2020 Apr 20.

3. 杜辰星*，邱录贵#, 多发性骨髓瘤的预后与分层策略, 国际输血及血液学杂志, 2017, 40(2): 113-119.